Preliminary Antiviral Response Observed Following PSI-7851 Administered as Monotherapy for 3 Days -------------------------------------------------------------------------- Dose N Mean Change in HCV RNA at Day 3 (Log(10)) -------------------------------------------------------------------------- 50mg QD 8 -0.49 100mg QD 8 -0.61 200mg QD 8 -1.01 Placebo 6 -0.03 --------------------------------------------------------------------------
I totally missed this release on Friday given that it was at 7am. Thanks for posting.
So, if we compare the 100mg qd dose to that of IDX-184, IDX-184 was actually more potent, given a -0.74 mean decrease vs. a -0.61 mean decrease for PSI-7851. I think the bottom line is that IDIX needs to consider a 200mg qd dose in the next trial.